Provided by Tiger Trade Technology Pte. Ltd.

Defiance Daily Target 2X Long MRNA ETF

79.50
+2.613.39%
Post-market: 77.79-1.7100-2.15%19:56 EDT
Volume:478.38K
Turnover:37.90M
Market Cap:34.19M
PE:- -
High:83.50
Open:72.03
Low:72.03
Close:76.89
52wk High:143.84
52wk Low:14.95
Shares:430.00K
Float Shares:430.00K
Volume Ratio:0.76
T/O Rate:111.25%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

US Treasury Steps In to Calm Markets, Ending Wall Street's Three-Day Slide, While Moderna's Cancer Vaccine Breakthrough Sends Shares Soaring 176%

Stock News
·
Aug 20

Today’s Market Recap:U.S. Treasury Steps In to Stabilize Markets,Stocks Rally, Bitcoin Breaks $70,000, Moderna Surges 180%

TradingKey
·
Aug 20

ETF Daily | MRNX Soars 352%; MRNY Surges 169%; TEMC, TEMT Jump 48%; NUGT Climbs 18%; Gold Miners and Biotech Lead

ETF Tracker
·
Aug 20

Moderna Shares Surge 177% on Promising Cancer Vaccine Data, Crushing Short Sellers with $5.5 Billion in Losses

Stock News
·
Aug 20

24H | Crypto Stocks Jump Again; Chip, Optical Communications Stocks Rebound; Moderna Pull Back After a 177% Surge

US Overnight
·
Aug 20

Option Focus | Moderna's $525K Bear Call Spread and $1.67M Long-Dated Put Buy Reveal Institutions Bracing for a Major Downside Move

Option Witch
·
Aug 20

NASD Most Active Issues

Dow Jones
·
Aug 20

One Great Chart: Moderna Surge Makes S&P History

Dow Jones
·
Aug 20

Moderna price target raised to $89 from $39 at Morgan Stanley

TIPRANKS
·
Aug 20

Moderna Inc. Stock Rallies 177.0%, Outperforms Peers

Dow Jones
·
Aug 20

Moderna's Cancer-Vaccine Breakthrough Drives Broad Biopharma Stock Rally

Dow Jones
·
Aug 20

US Stocks Close: Dow Rises Over 120 Points, SOX Drops 2%; Memory Stocks Lead Losses, SanDisk Falls 3.5%, Moderna Surges 177%

TradingKey
·
Aug 20

US Closing Bell | Unable to generate due to lack of news data

US Closing Bell
·
Aug 20

Moderna Shares More than Double on Success of mRNA Cancer Vaccine

Dow Jones
·
Aug 20

Moderna Raised to Outperform from Market Perform by William Blair

Dow Jones
·
Aug 20

Piper Sandler Adjusts Price Target on Moderna to $167 From $77, Maintains Overweight Rating

MT Newswires Live
·
Aug 20

BofA Securities Upgrades Moderna to Neutral From Underperform Following Intismeran 'Success', Raises Price Target to $170 From $40

MT Newswires Live
·
Aug 20

Asia Morning Call-Global Markets

Reuters
·
Aug 20

Top Midday Gainers

MT Newswires Live
·
Aug 20

U.S. Stocks on the MOVE-ServiceNow, Zoom, US Homebuilders

Reuters
·
Aug 20